Female Fertility Rapid Tests - Global Medical Devices Pipeline Assessment Report, 2019 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 19, 2019--
The “Female Fertility Rapid Tests - Medical Devices Pipeline Assessment, 2019” report has been added to ResearchAndMarkets.com’s offering.
This report provides an overview of Female Fertility Rapid Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development.
The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Female Fertility Rapid Tests pipeline products.
Scope
Reasons to Buy
Key Topics Covered
1 Table of Contents
2 Introduction
2.1 Female Fertility Rapid Tests Overview
3 Products under Development
3.1 Female Fertility Rapid Tests - Pipeline Products by Stage of Development
3.2 Female Fertility Rapid Tests - Pipeline Products by Segment
3.3 Female Fertility Rapid Tests - Pipeline Products by Territory
3.4 Female Fertility Rapid Tests - Pipeline Products by Regulatory Path
3.5 Female Fertility Rapid Tests - Pipeline Products by Estimated Approval Date
4 Female Fertility Rapid Tests - Pipeline Products under Development by Companies
4.1 Female Fertility Rapid Tests Companies - Pipeline Products by Stage of Development
4.2 Female Fertility Rapid Tests - Pipeline Products by Stage of Development
5 Female Fertility Rapid Tests Companies and Product Overview
5.1 BBB Technologies Inc Company Overview
5.2 Bio-AMD Inc.
5.3 ET Healthcare Inc.
5.4 MFB Fertility Inc.
5.5 NG Biotech
5.6 OPKO Health Inc.
5.7 Pop Test LLC
5.8 PragmaDX Inc.
5.9 Quidel Corp.
6 Female Fertility Rapid Tests - Recent Developments
6.1 Aug 08, 2019: Quidel reports second quarter 2019 Financial Results
6.2 May 28, 2019: True Diagnostics receives FDA 510(k) clearance to market VeriClear Digital Test Device for early result pregnancy
6.3 May 14, 2019: Sekisui Diagnostics invests $1.9 million in Microbial Biopharma CDMO business
6.4 May 08, 2019: Quidel reports first quarter 2019 financial results
6.5 Apr 01, 2019: Mologic expands US and UK operations
6.6 Feb 27, 2019: Sekisui Diagnostics expanding again and adding more jobs
6.7 Feb 13, 2019: Quidel Reports Fourth Quarter and Full Year 2018 Financial Results
6.8 Jan 07, 2019: Quidel Announces Preliminary Revenue for Fourth Quarter 2018
6.9 Nov 06, 2018: Quidel reports third quarter 2018 financial results
List of Tables
Table 1: Female Fertility Rapid Tests - Pipeline Products by Stage of Development
Table 2: Female Fertility Rapid Tests - Pipeline Products by Segment
Table 3: Female Fertility Rapid Tests - Pipeline Products by Territory
Table 4: Female Fertility Rapid Tests - Pipeline Products by Regulatory Path
Table 5: Female Fertility Rapid Tests - Pipeline Products by Estimated Approval Date
Table 6: Female Fertility Rapid Tests Companies - Pipeline Products by Stage of Development
Table 7: Female Fertility Rapid Tests - Pipeline Products by Stage of Development
Table 8: BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: ET Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 35: MFB Fertility Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 38: NG Biotech Pipeline Products & Ongoing Clinical Trials Overview
Table 47: OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Pop Test LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 53: PragmaDX Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 56: Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Glossary
List of Figures
Figure 1: Female Fertility Rapid Tests - Pipeline Products by Stage of Development
Figure 2: Female Fertility Rapid Tests - Pipeline Products by Segment
Figure 3: Female Fertility Rapid Tests - Pipeline Products by Territory
Figure 4: Female Fertility Rapid Tests - Pipeline Products by Regulatory Path
Figure 5: Female Fertility Rapid Tests - Pipeline Products by Estimated Approval Date
For more information about this report visit https://www.researchandmarkets.com/r/sx5ha3
View source version on businesswire.com:https://www.businesswire.com/news/home/20191119005960/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH WOMEN CONSUMER MEDICAL DEVICES
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 11/19/2019 01:46 PM/DISC: 11/19/2019 01:46 PM
http://www.businesswire.com/news/home/20191119005960/en